Drug Type Small molecule drug |
Synonyms CLX A102, CLXA102 |
Action modulators |
Mechanism 5-HT2 receptor modulators(Serotonin 2 (5-HT2) receptor modulators), D2 receptor modulators(Dopamine D2 receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bipolar and Related Disorders | Preclinical | India | 10 Jul 2024 | |
Bipolar Disorder | Preclinical | India | 01 Jul 2024 | |
Schizophrenia | Preclinical | India | 01 Jul 2024 |